We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

217 hedge funds and large institutions have $2.36B invested in Select Medical in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 70 increasing their positions, 95 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $958K

3% less capital invested

Capital invested by funds: $2.44B → $2.36B (-$74.7M)

1.75% less ownership

Funds ownership: 143.89%142.14% (-1.8%)

10% less funds holding

Funds holding: 240217 (-23)

26% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 95

45% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 33

Holders
217
Holders Change
-23
Holders Change %
-9.58%
% of All Funds
3.66%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
18
Increased
70
Reduced
95
Closed
33
Calls
$1.03M
Puts
$958K
Net Calls
+$68K
Net Calls Change
-$786K
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$544M +$9.45M +736,123 +2%
BlackRock
2
BlackRock
New York
$411M -$28M -2,179,260 -6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$285M -$19M -1,476,701 -6%
LSV Asset Management
4
LSV Asset Management
Illinois
$133M +$5.47M +426,008 +4%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$109M +$321K +24,977 +0.3%
State Street
6
State Street
Massachusetts
$95.2M -$1.18M -92,071 -1%
CCM
7
Camber Capital Management
Massachusetts
$94.5M +$71.5M +5,568,000 +300%
Macquarie Group
8
Macquarie Group
Australia
$52.5M +$356K +27,712 +0.7%
Principal Financial Group
9
Principal Financial Group
Iowa
$47.6M +$1.11M +86,614 +2%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$42.3M -$856K -66,679 -2%
Victory Capital Management
11
Victory Capital Management
Texas
$37.4M +$6.23M +485,112 +20%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$34.4M -$581K -45,253 -2%
Northern Trust
13
Northern Trust
Illinois
$28.8M -$959K -74,720 -3%
Charles Schwab
14
Charles Schwab
California
$28.4M +$1.59M +123,897 +6%
Fuller & Thaler Asset Management
15
Fuller & Thaler Asset Management
California
$26.8M -$16M -1,243,527 -37%
Norges Bank
16
Norges Bank
Norway
$26.1M -$2.47M -192,215 -9%
Morgan Stanley
17
Morgan Stanley
New York
$25.4M +$5.91M +460,772 +30%
Nuveen
18
Nuveen
North Carolina
$17.7M -$15.8M -1,232,562 -47%
Invesco
19
Invesco
Georgia
$16.9M -$5.26M -409,616 -24%
PAM
20
Panagora Asset Management
Massachusetts
$13.6M +$287K +22,373 +2%
Ameriprise
21
Ameriprise
Minnesota
$11M -$1.97M -153,347 -15%
Goldman Sachs
22
Goldman Sachs
New York
$10.8M -$1.39M -107,937 -11%
RA
23
Royce & Associates
New York
$10.6M +$67.1K +5,224 +0.6%
SGCIA
24
Smith Graham & Co Investment Advisors
Texas
$10.4M -$104K -8,122 -1%
Voloridge Investment Management
25
Voloridge Investment Management
Florida
$9.05M +$1.58M +122,902 +21%

SEM Hedge Fund Activity: Q2 2022 in Review

217 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2022, worth a combined $2.36B — down 3.1% from $2.44B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of SEM and 18 opened new positions — a net loss of 15 holders — while 95 trimmed existing stakes and 70 added.

The largest buyer was Camber Capital Management, adding an estimated $71.5M. The largest seller was BlackRock, cutting an estimated $28M.

  • 217 institutional investors held Select Medical (SEM) as of Q2 2022, down from 240 in Q1 2022.
  • Funds reported $2.36B of Select Medical stock for Q2 2022, down 3.1% quarter-over-quarter.
  • 18 funds opened new Select Medical positions in Q2 2022 and 33 closed out, a net change of -15 holders.
  • The largest Select Medical buyer in Q2 2022 was Camber Capital Management, an estimated $71.5M added.
  • The largest Select Medical seller in Q2 2022 was BlackRock, an estimated $28M sold.

Based on aggregated 13F filings for Q2 2022.